SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001509190-18-000032
Filing Date
2018-06-08
Accepted
2018-06-08 16:19:34
Documents
12
Period of Report
2018-06-08
Effectiveness Date
2018-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A petx-20180608xdef14a.htm DEF 14A 825315
2 GRAPHIC petx-20180608xdef14ag001.jpg GRAPHIC 6874
3 GRAPHIC petx-20180608xdef14ag002.jpg GRAPHIC 613
4 GRAPHIC petx-20180608xdef14ag003.jpg GRAPHIC 611
5 GRAPHIC petx-20180608xdef14ag004.jpg GRAPHIC 611
6 GRAPHIC petx-20180608xdef14ag005.jpg GRAPHIC 5670
7 GRAPHIC petx-20180608xdef14ag006.jpg GRAPHIC 991
8 GRAPHIC petx-20180608xdef14ag007.jpg GRAPHIC 615
9 GRAPHIC petx-20180608xdef14ag008.jpg GRAPHIC 6047
10 GRAPHIC petx-20180608xdef14ag009.jpg GRAPHIC 48326
11 GRAPHIC petx-20180608xdef14ag010.jpg GRAPHIC 62649
12 GRAPHIC petx-20180608xdef14ag011.jpg GRAPHIC 78646
  Complete submission text file 0001509190-18-000032.txt   1119583
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35952 | Film No.: 18889708
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1